Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 139, Issue , 2018, Pages 122-130

  Kurinami, Noboru ^a   Sugiyama, Seigo ^a   Morita, Ayami ^a   Yoshida, Akira ^a   Hieshima, Kunio ^a   Miyamoto, Fumio ^a   Kajiwara, Keizo ^a   Jinnouch, Katsunori ^a   Jinnouchi, Tomio ^a   Jinnouchi, Hideaki ^a  

^a Jinnouchi Hospital   (Japan)

Author keywords

Body fat; Body muscle; Diabetes mellitus; Ectopic fat accumulation; Fat; Insulin resistance; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE;

ABDOMINAL RADIOGRAPHY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTIC METHOD; ANTHROPOMETRIC PARAMETERS; ANTHROPOMETRY; ARTICLE; BIOELECTRICAL IMPEDANCE ANALYSIS; BLOOD EXAMINATION; BODY COMPOSITION; BODY FAT; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FAT MASS; FATTY LIVER; FEMALE; HUMAN; LIVER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; ODDS RATIO; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPLEEN; BLOOD; COMPLICATION; IMPEDANCE; MIDDLE AGED; OBESITY; PATHOLOGY; PHYSIOLOGY; THERAPEUTIC USE;

ADIPOSITY; BODY COMPOSITION; DIABETES MELLITUS, TYPE 2; ELECTRIC IMPEDANCE; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY;

EID: 85044678085     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2018.02.009     Document Type: Article

References (34)

1. Vernon, G., Baranova, A., Younossi, Z.M., Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34 (2011), 274–285.
2. Kojima, H., Sakurai, S., Uemura, M., Fukui, H., Morimoto, H., Tamagawa, Y., Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis. Alcohol Clin Exp Res 31:1 Suppl (2007), S61–6.
3. El-Serag, H.B., Tran, T., Everhart, J.E., Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126 (2004), 460–468.
4. Bril, F., Cusi, K., Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: A CALL TO ACTION. Diabetes Care 40:3 (2017), 419–430.
5. Mantovani, A., Targher, G., Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. Ann Transl Med, 5(13), 2017, 270.
6. Hotta, N., Nakamura, J., Iwamoto, Y., Ohno, Y., Kasuga, M., Kikkawa, R., et al. Causes of death in Japanese diabetics: a questionnaire survey of 18,385 diabetics over a 10-year period. J Diabetes Investig 1:1–2 (2010), 66–76.
7. Saadeh, S., Younossi, Z.M., Remer, E.M., Gramlich, T., Ong, J.P., Hurley, M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123 (2002), 745–750.
8. Akter, Shamima, Goto, Atsushi, Mizoue, Tetsuya, Smoking and the risk of type 2 diabetes in Japan: a systematic review and meta-analysis. J Epidemiol 27 (2017), 553–561.
9. Abenavoli, L., Luigiano, C., Guzzi, P.H., Milic, N., Morace, C., Stelitano, L., et al. Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease. Panminerva Med 56 (2014), 189–193.
10. Kato, K., Takamura, T., Takeshita, Y., Ryu, Y., Misu, H., Ota, T., et al. Ectopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease. PLoS ONE, 9(3), 2014, e92170.
11. Korenblat, K.M., Fabbrini, E., Mohammed, B.S., Klein, S., Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 134 (2008), 1369–1375.
12. Koda, M., Kawakami, M., Murawaki, Y., Senda, M., The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies. J Gastroenterol 42 (2007), 897–903.
13. Kurinami, N., Sugiyama, S., Yoshida, A., Hieshima, K., Miyamoto, F., Kajiwara, K., et al. Correlation of body muscle/fat ratio with insulin sensitivity using hyperinsulinemic-euglycemic clamp in treatment-naïve type 2 diabetes mellitus. DRCP 120 (2016), 65–72.
14. American Diabetes Association, Standards of medical care in diabetes—2010. Diabetes Care 33:Supplement 1 (2010 Jan), S11–S61.
15. Chalasani, N., Younossi, Z., Lavine, J.E., Diehl, A.M., Brunt, E.M., Cusi, K., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and the American College of Gastroenterology. Gastroenterology 142 (2012), 1592–1609.
16. Kan, H., Kimura, Y., Hyogo, H., Fukuhara, T., Fujino, H., Naeshiro, N., et al. Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease. Hepatology Res 44 (2014), E420–7.
17. Cha, K., Chertow, G.M., Gonzalez, J., Lazarus, J.M., Wilmore, D.W., Multifrequency bioelectrical impedance estimates the distribution of body water. J Appl Physiol 79:4 (1995), 1316–1319.
18. Cha, K., Shin, S., Shon, C., Choi, S., Wilmore, D.W., Evaluation of segmental bioelectrical impedance analysis (SIBA) for measuring muscle distribution. J ICHPER SD-ASIA, 1997, 11–14.
19. Sanada, K., Miyachi, M., Tanimoto, M., Yamamoto, K., Murakami, H., Okumura, S., et al. A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol 110:1 (2010), 57–65.
20. Everhart, J.E., Bambha, K.M., Fatty liver: think globally. Hepatology 51 (2010), 1491–1493.
21. Eguchi, Y., Eguchi, T., Mizuta, T., Ide, Y., Yasutake, T., Iwakiri, R., et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol 41 (2006), 462–469.
22. Yamauchi, T., Kadowaki, T., Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab 17 (2013), 185–196.
23. Roldan-Valadez E, Favila R, Martínez-López M, Uribe M, Méndez-Sánchez N. Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease. Ann Hepatol 2008; 7(3): 212–20 [Jul-Sep].
24. Iwasaki, M., Takada, Y., Hayashi, M., Minamiguchi, S., Haga, H., Maetani, Y., et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 78:10 (2004 Nov 27), 1501–1505.
25. Kelley, D.E., McKolanis, T.M., Hegazi, R.A.F., Kuller, L.H., Kalhan, S.C., Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 285 (2003), E906–16.
26. Yoo, H.J., Park, M.S., Lee, C.H., Yang, S.J., Kim, T.N., Lim, K.I., et al. Cutoff points of abdominal obesity indices in screening for non-alcoholic fatty liver disease in Asians. Liver Int 30 (2010), 1189–1196.
27. Ishibashi, E., Eguchi, Y., Eguchi, T., Matsunobu, A., Oza, N., Nakashita, S., et al. Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females. J Gastroenterol Hepatol 23 (2008), 908–913.
28. Cusi, K., Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 142 (2012), 711–725.
29. Sakurai, M., Takamura, T., Ota, T., Ando, H., Akahori, H., Kaji, K., et al. Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease. J Gastroenterol 42 (2007), 312–317.
30. Schindhelm, R.K., Diamant, M., Dekker, J.M., Tushuizen, M.E., Teerlink, T., Heine, R.J., Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 22 (2006), 437–443.
31. McPherson, S., Stewart, S.F., Henderson, E., Burt, A.D., Day, C.P., Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 59:9 (2010 Sep), 1265–1269.
32. Chang, Y., Ryu, S., Sung, E., Jang, Y., Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 53 (2007), 686–692.
33. Cruz-Jentoft, A.J., Landi, F., Schneider, S.M., Zúñiga, C., Arai, H., Boirie, Y., et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43 (2014), 748–759.
34. Santilli, V., Bernetti, A., Mangone, M., Paoloni, M., Clinical definition of sarcopenia. Clin Cases Miner Bone Metab 11 (2014), 177–180.